US Patent Issued to Hadasit Medical Research Services & Development, Yissum Research Development Company of the Hebrew University of Jersusalem on Sept. 29 for "Methods and compositions for preventing skin toxicities caused by biological targeted cancer drugs" (Israeli Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,219, issued on Sept. 29, was assigned to Hadasit Medical Research Services & Development Ltd. (Jerusalem) and Yissum Research Development Co. of the Hebrew University of Jersusalem Ltd..

"Methods and compositions for preventing skin toxicities caused by biological targeted cancer drugs" was invented by Ofra Benny (Mevasseret Zion, Israel), Sharon Merims (Bat Hefer, Israel) and Yelena Mostinski (Kokhav Yair, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for inhibiting binding of systemically administered drugs to a target in the skin by topically administering materials prior to or concomitantly with administration of th...